Literature DB >> 18632778

Smoking worsens the prognosis in multiple sclerosis.

P Sundström1, L Nyström.   

Abstract

OBJECTIVE: To estimate the effect of smoking on the risk for progression in multiple sclerosis (MS).
METHODS: Self-reported data were used on smoking habits in 122 incident cases with disability assessments made after a median of 6 years disease duration.
RESULTS: Ever smokers were more likely to have progressive disease compared with never smokers (P < 0.01). This was most pronounced in ever smokers with early smoking debut (< or = 15 years of age) for whom progressive disease was significantly more likely and occurred at an earlier age, compared with those with later smoking debut (P < 0.01 for both) or never smokers (P < 0.01 for both). Earlys moking start also predisposed to a progressive disease from onset when compared with never smokers (P = 0.012). A multivariate Cox regression analysis of sex, age at disease onset (above vs. under median) and smoking (ever vs. never) status showed that cases with late disease onset had three times higher risk and ever smokers had twice as high a risk for progression.
CONCLUSION: Past smoking is associated with a worsened prognosis in MS. The negative effect from smoking is most obvious in ever smokers with early smoking debut, which also affects MS phenotype significantly.

Entities:  

Mesh:

Year:  2008        PMID: 18632778     DOI: 10.1177/1352458508093615

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  28 in total

1.  Smoking: effects on multiple sclerosis susceptibility and disease progression.

Authors:  Dean M Wingerchuk
Journal:  Ther Adv Neurol Disord       Date:  2012-01       Impact factor: 6.570

Review 2.  Lifestyle and Environmental Factors in Multiple Sclerosis.

Authors:  Lars Alfredsson; Tomas Olsson
Journal:  Cold Spring Harb Perspect Med       Date:  2019-04-01       Impact factor: 6.915

Review 3.  Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis.

Authors:  Tomas Olsson; Lisa F Barcellos; Lars Alfredsson
Journal:  Nat Rev Neurol       Date:  2016-12-09       Impact factor: 42.937

4.  Association of smoking with risk of multiple sclerosis: a population-based study.

Authors:  Sreeram V Ramagopalan; Joshua D Lee; Irene M Yee; Colleen Guimond; Anthony L Traboulsee; George C Ebers; A Dessa Sadovnick
Journal:  J Neurol       Date:  2013-03-02       Impact factor: 4.849

5.  Influence of cigarette smoking on white matter in patients with clinically isolated syndrome as detected by diffusion tensor imaging.

Authors:  Gamze Durhan; Sevda Diker; Arzu Ceylan Has; Jale Karakaya; Asli Tuncer Kurne; Kader Karli Oguz
Journal:  Diagn Interv Radiol       Date:  2016 May-Jun       Impact factor: 2.630

6.  Smoking cessation for the neurologic patient.

Authors:  Jinny Tavee
Journal:  Neurol Clin Pract       Date:  2012-06

7.  Contribution of vitamin D insufficiency to the pathogenesis of multiple sclerosis.

Authors:  Charles Pierrot-Deseilligny; Jean-Claude Souberbielle
Journal:  Ther Adv Neurol Disord       Date:  2013-03       Impact factor: 6.570

8.  Smoking is associated with increased lesion volumes and brain atrophy in multiple sclerosis.

Authors:  R Zivadinov; B Weinstock-Guttman; K Hashmi; N Abdelrahman; M Stosic; M Dwyer; S Hussein; J Durfee; M Ramanathan
Journal:  Neurology       Date:  2009-08-18       Impact factor: 9.910

Review 9.  Modifiable comorbidities and disability in multiple sclerosis.

Authors:  Shannon Overs; Christina M Hughes; Jodie K Haselkorn; Aaron P Turner
Journal:  Curr Neurol Neurosci Rep       Date:  2012-10       Impact factor: 5.081

10.  Tobacco smoking and disability progression in multiple sclerosis: United Kingdom cohort study.

Authors:  Ali Manouchehrinia; Christopher R Tench; Jonathan Maxted; Rashid H Bibani; John Britton; Cris S Constantinescu
Journal:  Brain       Date:  2013-06-11       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.